Skip to main content

We narrowed to 80 results for: otos

Showing: 21 - 40 of 80 results
  1. pAAV-TRE-DIO-eYFP (AAV1)

    Viral Prep
    #117383-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-TRE-DIO-eYFP (#117383). In addition to the viral particles, you will also receive purified pAAV-TRE-DIO-eYFP plasmid DNA. Tet-inducible, Cre-dependent eYFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    TRE
    Tags
    eYFP (Tet-inducible, Cre-dependent)
    Available Since
    Jan. 6, 2022
    Availability
    Academic Institutions and Nonprofits only
  2. AAV-FLEX-Arch-GFP (AAV9)

    Viral Prep
    #22222-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from AAV-FLEX-Arch-GFP (#22222). In addition to the viral particles, you will also receive purified AAV-FLEX-Arch-GFP plasmid DNA. CAG-driven cre-dependent Arch-GFP expression for optogenetic neural inhibition. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Tags
    GFP (Cre-dependent)
    Available Since
    Feb. 20, 2018
    Availability
    Academic Institutions and Nonprofits only
  3. pGP-AAV-syn-flex-iGABASnFR2-WPRE (AAV1)

    Viral Prep
    #218877-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pGP-AAV-syn-flex-iGABASnFR2-WPRE (#218877). In addition to the viral particles, you will also receive purified pGP-AAV-syn-flex-iGABASnFR2-WPRE plasmid DNA. Syn-driven, Cre-dependent expression of the improved GABA sensor iGABASnFR2 (positive change in fluorescence). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    None
    Available Since
    Sept. 27, 2024
    Availability
    Academic Institutions and Nonprofits only
  4. pAAV-hSyn1-eYFP (AAV Retrograde)

    Viral Prep
    #117382-AAVrg
    Purpose
    Ready-to-use AAV Retrograde particles produced from pAAV-hSyn1-eYFP (#117382). In addition to the viral particles, you will also receive purified pAAV-hSyn1-eYFP plasmid DNA. hSyn-driven eYFP expression. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    eYFP
    Available Since
    Oct. 18, 2021
    Availability
    Academic Institutions and Nonprofits only
  5. pAAV-hsyn-GRAB_5-HT1.0 (AAV9)

    Viral Prep
    #140552-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-hsyn-GRAB_5-HT1.0 (#140552). In addition to the viral particles, you will also receive purified pAAV-hsyn-GRAB_5-HT1.0 plasmid DNA. Synapsin-driven expression of GRAB_5-HT1.0 sensor. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    None
    Available Since
    Aug. 31, 2021
    Availability
    Academic Institutions and Nonprofits only
  6. AAV-CAG-hChR2-H134R-tdTomato (AAV Retrograde)

    Viral Prep
    #28017-AAVrg
    Purpose
    Ready-to-use AAV Retrograde particles produced from AAV-CAG-hChR2-H134R-tdTomato (#28017). In addition to the viral particles, you will also receive purified AAV-CAG-hChR2-H134R-tdTomato plasmid DNA. Humanized channelrhodopsin H134R mutant fused to tdTomato, under the control of the CAG promoter. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Tags
    tdTomato
    Available Since
    June 20, 2017
    Availability
    Academic Institutions and Nonprofits only
  7. AAV-FLEX-Arch-GFP (AAV1)

    Viral Prep
    #22222-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from AAV-FLEX-Arch-GFP (#22222). In addition to the viral particles, you will also receive purified AAV-FLEX-Arch-GFP plasmid DNA. CAG-driven cre-dependent Arch-GFP expression for optogenetic neural inhibition. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Tags
    GFP (Cre-dependent)
    Available Since
    Feb. 21, 2018
    Availability
    Academic Institutions and Nonprofits only
  8. pAAV-hSyn1-eYFP (AAV PHP.eB)

    Viral Prep
    #117382-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV-hSyn1-eYFP (#117382). In addition to the viral particles, you will also receive purified pAAV-hSyn1-eYFP plasmid DNA. hSyn-driven eYFP expression. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    eYFP
    Available Since
    Jan. 6, 2022
    Availability
    Academic Institutions and Nonprofits only
  9. pAAV.CAGFLEX.(cyto).iATPSnFR2.S29W.A95K.HaloTag (AAV5)

    Viral Prep
    #209655-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV.CAGFLEX.(cyto).iATPSnFR2.S29W.A95K.HaloTag (#209655). In addition to the viral particles, you will also receive purified pAAV.CAGFLEX.(cyto).iATPSnFR2.S29W.A95K.HaloTag plasmid DNA. CAG-driven, Cre-dependent expression of the high affinity ATP biosensor iATPSnFR2. These AAV preparations are suitable purity for injection into animals.
    Promoter
    CAG
    Tags
    None
    Available Since
    Oct. 21, 2024
    Availability
    Academic Institutions and Nonprofits only
  10. pGP-AAV-syn-flex-iGABASnFR2-WPRE (AAV5)

    Viral Prep
    #218877-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pGP-AAV-syn-flex-iGABASnFR2-WPRE (#218877). In addition to the viral particles, you will also receive purified pGP-AAV-syn-flex-iGABASnFR2-WPRE plasmid DNA. Syn-driven, Cre-dependent expression of the improved GABA sensor iGABASnFR2 (positive change in fluorescence). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    None
    Available Since
    Sept. 27, 2024
    Availability
    Academic Institutions and Nonprofits only
  11. pAAV_hSyn_WiChR_TS_mScarlet_ER (AAV9)

    Viral Prep
    #205997-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV_hSyn_WiChR_TS_mScarlet_ER (#205997). In addition to the viral particles, you will also receive purified pAAV_hSyn_WiChR_TS_mScarlet_ER plasmid DNA. hSyn-driven K+ selective channelrhodopsin for optogenetic inhibition of neurons. These AAV preparations are suitable purity for injection into animals.
    Promoter
    Syn
    Tags
    mScarlet
    Available Since
    July 30, 2025
    Availability
    Academic Institutions and Nonprofits only
  12. pAAV-CAG-eYFP (AAV Retrograde)

    Viral Prep
    #104055-AAVrg
    Purpose
    Ready-to-use AAV Retrograde particles produced from pAAV-CAG-eYFP (#104055). In addition to the viral particles, you will also receive purified pAAV-CAG-eYFP plasmid DNA. CAG-driven eYFP expression control. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Tags
    EYFP
    Available Since
    Jan. 6, 2022
    Availability
    Academic Institutions and Nonprofits only
  13. pAAV-FLEX-P301L Tau (AAV1)

    Viral Prep
    #176267-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-FLEX-P301L Tau (#176267). In addition to the viral particles, you will also receive purified pAAV-FLEX-P301L Tau plasmid DNA. EF1a-driven, Cre-dependent expression of human 2N4R microtubule-associated protein tau with P301L mutation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Tags
    None
    Available Since
    Aug. 7, 2025
    Availability
    Academic Institutions and Nonprofits only
  14. pAAV-CAG-eYFP (AAV PHP.eB)

    Viral Prep
    #104055-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV-CAG-eYFP (#104055). In addition to the viral particles, you will also receive purified pAAV-CAG-eYFP plasmid DNA. CAG-driven eYFP expression control. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Tags
    EYFP
    Available Since
    June 13, 2023
    Availability
    Academic Institutions and Nonprofits only
  15. pGP-AAV-syn-iGABASnFR2(no bind)-WPRE (AAV5)

    Viral Prep
    #218876-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pGP-AAV-syn-iGABASnFR2(no bind)-WPRE (#218876). In addition to the viral particles, you will also receive purified pGP-AAV-syn-iGABASnFR2(no bind)-WPRE plasmid DNA. Syn-driven expression of the improved GABA sensor control iGABASnFR2(no bind) (no change in fluorescence). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    None
    Available Since
    Sept. 27, 2024
    Availability
    Academic Institutions and Nonprofits only
  16. pGP-AAV-GFAP-iGABASnFR2(no bind)-WPRE (AAV1)

    Viral Prep
    #218873-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pGP-AAV-GFAP-iGABASnFR2(no bind)-WPRE (#218873). In addition to the viral particles, you will also receive purified pGP-AAV-GFAP-iGABASnFR2(no bind)-WPRE plasmid DNA. GFAP-driven expression of the improved GABA sensor control iGABASnFR2(no bind) (no change in fluorescence). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    GFAP
    Tags
    None
    Available Since
    Sept. 27, 2024
    Availability
    Academic Institutions and Nonprofits only
  17. pAAV-CAG-NLS-GFP (AAV PHP.eB)

    Viral Prep
    #104061-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV-CAG-NLS-GFP (#104061). In addition to the viral particles, you will also receive purified pAAV-CAG-NLS-GFP plasmid DNA. CAG-driven NLS-GFP expression. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Tags
    GFP
    Available Since
    March 5, 2019
    Availability
    Academic Institutions and Nonprofits only
  18. pAAV-CAG-DIO-EYFP (AAV PHP.V1)

    Viral Prep
    #104052-AAVPHP.V1
    Purpose
    Ready-to-use AAV PHP.V1 particles produced from pAAV-CAG-DIO-EYFP (#104052). In addition to the viral particles, you will also receive purified pAAV-CAG-DIO-EYFP plasmid DNA. CAG-driven, Cre-dependent expression of EYFP. These AAV were produced with the PHP.V1 serotype, which permits efficient transduction of brain vascular cells. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Tags
    EYFP (Cre-dependent)
    Available Since
    July 24, 2020
    Availability
    Academic Institutions and Nonprofits only
  19. pGP-AAV-syn-flex-iGABASnFR2(no bind)-WPRE (AAV1)

    Viral Prep
    #218879-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pGP-AAV-syn-flex-iGABASnFR2(no bind)-WPRE (#218879). In addition to the viral particles, you will also receive purified pGP-AAV-syn-flex-iGABASnFR2(no bind)-WPRE plasmid DNA. Syn-driven, Cre-dependent expression of the improved GABA sensor control iGABASnFR2(no bind) (no change in fluorescence). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    None
    Available Since
    Oct. 21, 2024
    Availability
    Academic Institutions and Nonprofits only
  20. pAAV-syn-jYCaMP1s (AAV1)

    Viral Prep
    #135424-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-syn-jYCaMP1s (#135424). In addition to the viral particles, you will also receive purified pAAV-syn-jYCaMP1s plasmid DNA. Synapsin-driven expression of calcium sensor YCaMP1s. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    None
    Available Since
    July 22, 2020
    Availability
    Academic Institutions and Nonprofits only
Showing: 21 - 40 of 80 results